Building uncertainty into cost-effectiveness rankings portfolio risk-return tradeoffs and implications for decision rules

Medical Care

Volumn 38, Issue 5, 2000, Pages 460-468

  O'Brien, Bernie J ^a   Sculpher, Mark J ^b  

^a ST JOSEPH S HOSPITAL   (Canada)

^b UNIVERSITY OF YORK   (United Kingdom)

Author keywords

Cost effectiveness; Diversification; Portfolio theory; Resource allocation; Risk return

Indexed keywords

ARTICLE; COST BENEFIT ANALYSIS; DECISION SUPPORT SYSTEM; ECONOMICS; HEALTH CARE ORGANIZATION; HUMAN; INVESTMENT; METHODOLOGY; ORGANIZATION; QUALITY ADJUSTED LIFE YEAR; REIMBURSEMENT; RISK MANAGEMENT; STATISTICS;

COST-BENEFIT ANALYSIS; DECISION MAKING, ORGANIZATIONAL; DECISION SUPPORT TECHNIQUES; HEALTH CARE RATIONING; HUMANS; INVESTMENTS; QUALITY-ADJUSTED LIFE YEARS; REIMBURSEMENT MECHANISMS; RISK SHARING, FINANCIAL;

EID: 0034184455     PISSN: 00257079     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005650-200005000-00003     Document Type: Article

References (19)

1. O'Brien BJ, Drummond MF, Labelle R, Willan A. In search of power and significance: Issues in the design and analysis of stochastic cost-effectiveness studies in health care. Med Care 1994;32:150-163.
2. Wakker P, Klassen M. Confidence intervals for cost-effectiveness. Health Econ 1995;4:373-382.
3. Willan A, O'Brien BJ. Confidence intervals for cost-effectiveness ratios: An application of Fieller's theorem. Health Econ 1996;5:297-305.
4. Chaudhary MA, Stearns SC. Estimating confidence intervals for cost-effectiveness ratios: An example from a randomized trial. Stat Med 1996;15:1447-1458.
5. Briggs AH, Wonderling DE, Mooney CZ. Pulling cost-effectiveness analysis up by its bootstraps: A non-parametric approach to confidence interval estimation. Health Econ 1997;6:327-340.
6. Van Hout BA, Al MJ, Gordon GS, Rutten FF. Costs, effects and C/E-ratios: Alongside a clinical trial. Health Econ 1994;3:309-319.
7. Polsky D, Glick HA, Willke R, Schulman K. Confidence intervals for cost-effectiveness ratios: a comparison of four methods. Health Econ 1997;6:243-252.
8. Briggs AH, Mooney CZ, Wonderling DE. Constructing confidence intervals around cost-effectiveness ratios: An evaluation of parametric and non-parametric methods using Monte Carlo simulation. Stat Med 1999;18:3245-3262.
9. Hunink MG, Bult JR, deVries J, Weinstein MC. Uncertainty in decision models analyzing cost-effectiveness: The joint distribution of incremental costs and effectiveness evaluated with nonparametric bootstrap method. Med Decis Making 1998;18:337-346.
10. Claxton K. Bayesian approaches to the value of information: Implications for the regulation of new pharmaceuticals. Health Econ 1999;8:269-274.
11. Arrow KJ, Lind RC. Uncertainty and the evaluation of public investment decisions. Am Econ Rev 1970;60:364-378.
12. Coombs CH, Huang L. Tests of a portfolio theory of risk preference. J Exp Psychol 1970;85:23-29.
13. Asch DA, Hershey JC. Why some health policies don't make sense at the bedside. Ann Intern Med 1995;122:846-850.
14. Graham JD. An investor's look at life-saving opportunities. In: Harvard Center for Risk Analysis, ed. Risk in perspective. Boston, Mass: Harvard School of Public Health; 1999:1-4.
15. Pratt JW, Raiffa H, Schlaifer R. Introduction to statistical decision theory. Cambridge, Mass: MIT Press; 1995:718.
16. Drummond MF, Richardson WS, O'Brien BJ, Levine M, Heyland D. Users' guides to the medical literature, XIII: How to use an article on economic analysis of clinical practice, part A: Are the results of the study valid? Evidence-Based Medicine Working Group. JAMA 1997;277:1552-1557.
17. Mark DB, Hlatky MA, Califf RM, Naylor CD, Lee KL, Armstrong PW. Cost-effectiveness of thrombolytic therapy with tissue plasminogen activator as compared with streptokinase for acute myocardial infarction. N Engl J Med 1995;332:1418-1424.
18. Stinnett AA, Mullahy J. Net health benefits: A new framework for the analysis of uncertainty in cost-effectiveness analysis. Med Decis Making 1998;18:S65-S80.
19. Tambour M, Zethraus N, Johannesson M. A. note on confidence intervals in cost-effectiveness analysis. Int J Technol Assess Health Care 1998;14-467-471.